A more selective investment climate, higher expectations for proven value, and longer exit paths are reshaping the landscape for life sciences companies. In 2026, access to capital is no longer merely a matter of financing; it has become a strategic competitive factor that determines which innovations reach patients and the market.
Johan Christenson, Chairman of the Board of Stockholm Science City Foundation, and Partner at HealthCap.
Johan Christenson is Chairman of the Board at Stockholm Science City and Partner at HealthCap.
Our newsletter focuses primarily on life science and highlights key players, topics and development within the innovation ecosystem in the Stockholm-Uppsala region.
